Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blind, Placebo-controlled Study Evaluating the Effect of Dupilumab on Sleep in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

NCT04033367 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT04033367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04033367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blind, Placebo-controlled Study Evaluating the Effect of Dupilumab on Sleep in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
August 22, 2019
Completion date
October 6, 2021
Enrollment
188 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis